Cargando…
Acceptability of a Long-Acting, Multipurpose Vaginal Ring: Findings from a Phase I Trial in the U.S. and Dominican Republic
BACKGROUND: Women worldwide face risks from pregnancy, HIV, and other sexually transmitted infections (STIs). To date, highly effective contraceptive methods provide no HIV/STI protection, and HIV prevention products, excluding condoms, provide no pregnancy protection. Intravaginal rings (IVRs) deli...
Autores principales: | Tolley, Elizabeth E., Zissette, Seth, Taylor, Jamilah, Hanif, Homaira, Ju, Susan, Schwarz, Jill, Thurman, Andrea, Tyner, Danielle, Brache, Vivian, Doncel, Gustavo F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527051/ https://www.ncbi.nlm.nih.gov/pubmed/35363574 http://dx.doi.org/10.1089/jwh.2021.0394 |
Ejemplares similares
-
Preferred product attributes of a multipurpose vaginal ring: Findings from a phase 1 trial
por: Tolley, Elizabeth E., et al.
Publicado: (2023) -
Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study
por: Thurman, Andrea R., et al.
Publicado: (2022) -
Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies
por: Thurman, Andrea Ries, et al.
Publicado: (2013) -
Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women
por: Thurman, Andrea Ries, et al.
Publicado: (2018) -
Adaptation and validation of simple tools to screen and monitor for oral PrEP adherence
por: Zissette, Seth, et al.
Publicado: (2021)